Domov › Dermatomiozitis › Massachusetts
Klinične študije za Dermatomiozitis v Massachusetts
5 študij za Dermatomiozitis išče udeležence na lokacijah v Massachusetts.
Mesta v Massachusetts
Uradno besedilo študije (angleško)
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
- Research Site, Boston
Vključevanje udeležencevFaza 3
Starost 18–75 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT06455449Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT03816345RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- Boston Children's Hospital - Accepting Young Adults and Juvenile Patients, Boston
Vključevanje udeležencevFaza 2/3
Starost 6–75 · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT06154252A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
- Brigham and Women's Hospital, Boston
- CTC - Brigham & Women's Hospital, Boston
- CTH - Brigham & Women's Hospital, Boston
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 15. sep. 2026 · NCT05895786A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
- Brigham And Womens Hospital, Boston
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 14. jul. 2026 · NCT07115745Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.